Targeting DCLK1 with these mAbs in xenograft mouse models from KRASG12D mutant human cell lines AsPC-1 or SW1990 or in the KPC mouse model led to significant inhibition of the tumor growth (Figures 5 and 6). The gene discussed is DCLK1; the disease is neoplasm.